CSIMarket
 


Pharmacyte Biotech Inc   (PMCB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Pharmacyte Biotech Inc 's Tangible Leverage Ratio

PMCB's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




PMCB Tangible Leverage Ratio (Jan 31 2020)
III. Quarter
(Oct 31 2019)
II. Quarter
(Jul 31 2019)
I. Quarter
(Apr 30 2019)
IV. Quarter
(Jan 31 2019)
III. Quarter
Y / Y Tangible Equity Change -57.61 % -46.89 % -45.25 % -32.86 % -20.64 %
Y / Y Total Liabilities Change 116.22 % 21.36 % -31.3 % 15.32 % -19.75 %
Tangible Leverage Ratio MRQ 1.32 0.82 0.42 0.5 0.26
Overall Ranking # # # # #
Seq. Tangible Equity Change -21.84 % -32.07 % -2.69 % -17.96 % -2.08 %
Seq. Total Liabilities Change 26.74 % 32.53 % -18.35 % 57.65 % -28.86 %



Tangible Leverage Ratio third quarter 2019 Comment
Due to net new borrowings of 26.74%, Tangible Leverage Ratio detoriated to 1.32, above company's average Tangible Leverage Ratio.

Within Biotechnology & Drugs industry in the third quarter 2019, 48 other companies have achieved lower Tangible Leverage Ratio than Pharmacyte Biotech Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is PMCB Market Share?
Tangible Leverage Ratio third quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 49
Healthcare Sector # 165
Overall Market # 356


Tangible Leverage Ratio Statistics
High Average Low
0.24 0.1 0.04
(Jan 31 2020)   (Apr 30 2014)




Financial Statements
Pharmacyte Biotech Inc 's Tangible Equity $ 1 Millions Visit PMCB's Balance sheet
Pharmacyte Biotech Inc 's Total Liabilities $ 1 Millions Visit PMCB's Balance sheet
Source of PMCB's Sales Visit PMCB's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingJan 31 2020, within Biotechnology & Drugs Industry Tangible Leverage RatioJan 31 2020 MRQ Total LiabilitiesJan 31 2020 MRQ Tangible Equity
Foamix Pharmaceuticals Ltd   3.62 $ 63.584  Millions$ 17.575  Millions
Cerecor Inc   3.61 $ 15.027  Millions$ 4.160  Millions
Biocryst Pharmaceuticals Inc  3.49 $ 133.624  Millions$ 38.252  Millions
Wave Life Sciences Ltd   3.46 $ 220.518  Millions$ 63.732  Millions
Champions Oncology Inc   3.43 $ 8.597  Millions$ 2.508  Millions
Cel Sci Corp  3.39 $ 22.540  Millions$ 6.658  Millions
Cyclo Therapeutics Inc   3.38 $ 3.161  Millions$ 0.936  Millions
Biogen Inc   3.32 $ 13,478.400  Millions$ 4,053.900  Millions
Pulmatrix Inc   3.28 $ 24.404  Millions$ 7.442  Millions
Tg Therapeutics inc   3.02 $ 114.181  Millions$ 37.816  Millions
Meridian Bioscience Inc  2.89 $ 140.836  Millions$ 48.748  Millions
Tracon Pharmaceuticals Inc   2.80 $ 7.548  Millions$ 2.698  Millions
Sellas Life Sciences Group Inc   2.46 $ 10.299  Millions$ 4.179  Millions
Coherus Biosciences inc   2.38 $ 242.337  Millions$ 101.651  Millions
Salarius Pharmaceuticals inc   1.93 $ 3.314  Millions$ 1.715  Millions
Aerie Pharmaceuticals Inc   1.71 $ 285.658  Millions$ 166.950  Millions
Neurocrine Biosciences Inc   1.53 $ 974.094  Millions$ 636.923  Millions
Immunomedics Inc   1.50 $ 399.669  Millions$ 267.230  Millions
Nanostring Technologies Inc   1.46 $ 151.837  Millions$ 104.151  Millions
Enochian Biosciences Inc  1.44 $ 6.816  Millions$ 4.735  Millions
Brickell Biotech Inc   1.39 $ 10.497  Millions$ 7.574  Millions
Surface Oncology Inc   1.32 $ 75.027  Millions$ 56.666  Millions
Pharmacyte Biotech Inc   1.32 $ 1.019  Millions$ 0.770  Millions
Genocea Biosciences Inc   1.10 $ 27.569  Millions$ 25.042  Millions
Chromadex Corp   1.03 $ 19.802  Millions$ 19.134  Millions
Merus N v   1.03 $ 132.076  Millions$ 128.424  Millions
Syndax Pharmaceuticals Inc  1.01 $ 31.925  Millions$ 31.600  Millions
Cv Sciences Inc   1.01 $ 22.817  Millions$ 22.593  Millions
Allena Pharmaceuticals Inc   0.95 $ 16.398  Millions$ 17.198  Millions
Protagonist Therapeutics Inc   0.94 $ 74.953  Millions$ 79.964  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMRT's Profile

Stock Price

SMRT's Financials

Business Description

Fundamentals

Charts & Quotes

SMRT's News

Suppliers

SMRT's Competitors

Customers & Markets

Economic Indicators

SMRT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071